Fresenius offers international diversification, stable healthcare exposure, and upside from a strategic pivot. Find out why ...

Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology, in ...

Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology, in collaboration with partners from Germany, the UK and USA, have developed and ...

Citi raised the firm’s price target on Fresenius Medical (FMS) to EUR 52.50 from EUR 46.50 and keeps a Neutral rating on the shares. Published ...

Citi raised the firm’s price target on Fresenius SE (FSNUY) to EUR 52 from EUR 43 and keeps a Buy rating on the shares. Published first on TheFly ...

Fresenius Medical Care (FME) has commenced the US commercialisation of its high-volume haemodiafiltration (HVHDF) kidney ...

FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.

Fresenius (FMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

A Monroe County kidney care center is expanding its services for End Stage Renal Disease. According to a State Health ...